Our client, a global MedTech company's internal growth forecasts were based on subjective supply-side assumptions and lacked data-driven objectivity. This made it challenging to secure leadership support for future investment plans. The client sought to develop a robust growth strategy for its International Markets, defining investment priorities and direction over the next three to five years with credible, realistic forecasts of market opportunities.
How we helped
Clearstate built a country-specific year-on-year growth forecast model using the Surgical Procedure Volume and Devices Tracker. We provided the underlying drivers of these forecasts, highlighting the macroeconomic, industry, and medical specialty factors influencing demand and supply across relevant product categories.